Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-04-12

FDA Approved: LOSARTAN POTASSIUM — Supplemental Application (Solco Healthcare US, LLC)

View source ↗

Summary

The FDA approved Solco Healthcare US, LLC's supplemental application for Losartan Potassium, a generic product, enabling its continued market authorization in t…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Losartan Potassium (Losartan potassium)

Snippet

SUPPL AP for LOSARTAN POTASSIUM (LOSARTAN POTASSIUM)